Mellow Bumps RCT - Antenatal Intervention for Vulnerable Women

Pregnancy Clinical Trial

Official title:

Antenatal Parenting Support for Women Vulnerable in Pregnancy: an Exploratory Randomised Controlled Trial of Mellow Bumps

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01590212
• Other study ID #: 12/WS/0024
• Status: Completed
• Phase: N/A
• First received: April 30, 2012
• Last updated: March 5, 2014
• Start date: May 2012
• Est. completion date: June 2013

Study information

• Verified date: March 2014
• Source: University of Glasgow
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: National Health Service
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to compare the effectiveness of a relationships based antenatal intervention (Mellow Bumps) against a comparison intervention (Chillout In Pregnancy) and also against the normal antenatal care which is received during pregnancy (Care As Usual). The Mellow Bumps intervention will seek to improve maternal anxiety and maternal sensitivity whilst the Chillout In Pregnancy intervention will aim to improve only maternal anxiety. This will allow the researchers to determine what type of intervention, if any, is most successful at improving the outcomes of the mother and child. This will be measured by looking at the mother's stress response, anxiety, depression and irritability, the baby's stress response and the interactions between the mother and the baby. Participants in the study will be pregnant women who would be between 20 and 30 weeks pregnant at the start of the antenatal intervention. Participants will be chosen to take part in one of the three conditions (Mellow Bumps, Chillout In Pregnancy or Care As Usual) at random. All participants will be asked to complete questionnaires and give saliva samples prior to the intervention. The questionnaires will also be repeated at the end of the intervention and at a follow up occurring eight to twelve weeks after birth. Consent will also be sought to take saliva samples from the baby before and after a routine blood test when the baby is five days old. This information will then be evaluated to establish the effectiveness of the proposed interventions.

Description:

Lower than anticipated recruitment numbers have resulted in changes to the planned methodology of this trial. Firstly, participants were allocated to the three arms in groups/blocks of 6. Secondly, randomisation of the final group recruited was abandoned.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: June 2013
• Est. primary completion date: June 2013
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• pregnant, between 20 & 30 weeks gestation at start of intervention

• Identified by midwives as meeting Special Needs in Pregnancy (SNiP) criteria

• basic understanding of written and spoken English

Exclusion Criteria:

• not identified as vulnerable through SNiP criteria

• less than 20 weeks or more than 30 weeks gestation at start of intervention

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Mental Health Wellness 1
• Mother-Child Relations
• Pregnancy

Intervention

Other:
• Mellow Bumps
Mellow Bumps is a six week group-based antenatal programme designed to support families with additional health and social care needs. It is intended to decrease maternal antenatal stress levels, increase expectant mothers' understanding of neonates' capacity for social interaction and emphasise the importance of early interaction in enhancing brain development and attachment. It is delivered non-didactically to maximise participant engagement and rapport. Each week there is one activity focused on the woman and another on a baby-related topic. The programme is designed to be offered between twenty to thirty weeks' gestation, to capture the period when the risk of miscarriage is low and fetal movement felt, but before major preoccupation with the delivery.
• Chill-out in Pregnancy
Chill Out in Pregnancy (ChIP) is a relaxation programme that includes all the mother centred components of Mellow Bumps but none of the baby / mother-baby relationship components. It also runs for six weeks at two hours per week and is intended to decrease stress levels.

Locations

Country	Name	City	State
United Kingdom	NHS Greater Glasgow & Clyde	Greenock	Inverclyde
United Kingdom	NHS Ayshire & Arran	Irvine	North Ayrshire

Sponsors (2)

Lead Sponsor	Collaborator
University of Glasgow	Scottish Collaboration for Public Health Research and Policy

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Anxiety, Depression and Irritability Measured on Adult Wellbeing Scale	Anxiety, depression and irritability measured on Adult Wellbeing Scale at 9-12 weeks after baseline.; The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains - depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),	Post intervention (approximately 9-12 weeks after baseline)	No
Primary	Depression Measured on EPDS	Depression as measured on the EPDS at 9-12 weeks after baseline; Edinburgh Postnatal Depression Scale (EPDS): is a standardised questionnaire which generates a single score. Normal score=0-9, Borderline=10-12, Probable depression=13-30.	Post-intervention (approximately 9 -12 weeks after baseline)	No
Primary	Anxiety, Depression and Irritability Measured on Adult Wellbeing Scale	Anxiety, depression and irritability measured on the Adult Wellbeing Scale post-birth (approximately 8-12 weeks postnatal); The Adult Wellbeing scale (AWS): a validated questionnaire which generates scores in four domains - depression, anxiety, outward-directed irritability and inward-directed irritability. The sub-scales have different cut-off scores that indicate a possible problem in that area: Anxiety (normal=0-5, borderline=6-8, problem 9-15), Depression (normal=0-3, borderline=4-6, problem 7-15), Outward directed irritability (normal=0-4, borderline=5-7, problem 8-12), Inward directed irritability (normal=0-3, borderline=4-6, problem 7-12),	Post-birth (8-12 weeks postnatal)	No
Primary	Depression Measured on EPDS	Depression scores as measured on the EPDS post-birth (approximately 8-12 weeks postnatal); Edinburgh Postnatal Depression Scale (EPDS): is a standardised questionnaire which generates a single score. Normal score=0-9, Borderline=10-12, Probable depression=13-30.	Post-birth (8-12 weeks postnatal)	No